Broadcom vs. Intel: Which Semiconductor Stock Is a Better Buy in 2026?

The article favors Broadcom over Intel for 2026, citing Broadcom's FY2025 revenue growth of 23.9% to $63.9B, 36.2% net margin, and $26.9B in free cash flow, versus Intel's 0.5% revenue decline to $52.9B, $267M net loss, and negative $4.9B free cash flow. Broadcom has supply commitments intended to double AI revenue again next year and benefits from AI-chip customers including Google, Meta, OpenAI, and Anthropic. Intel's U.S. government-backed turnaround and foundry expansion remain less proven, despite seven consecutive guidance beats, while its 64.4x forward P/E exceeds Broadcom's 30.6x.

Analysis

AVGO’s key valuation risk is not AI demand but conversion of booked custom-ASIC demand into durable, high-margin revenue after the initial deployment cycle. Hyperscalers use custom silicon to reduce dependence on NVDA and lower inference cost, which supports AVGO’s networking and ASIC content; however, success ultimately gives GOOG, META and other buyers greater negotiating leverage. The market is likely underpricing this mix shift: AVGO can grow revenue while its incremental gross-margin profile compresses if lower-margin semiconductor content outpaces VMware/software growth.

The cleaner second-order beneficiary is TSM, whose advanced-node capacity remains the common bottleneck across merchant AI, custom accelerators and smartphone silicon. AVGO’s concentrated manufacturing exposure makes any Taiwan-risk premium or leading-node capacity tightness a direct constraint on revenue timing, not merely a valuation issue. Conversely, AAPL’s large supply commitment is strategically useful for AVGO utilization but raises the probability that a handset-cycle slowdown coincides with a hyperscaler capex digestion period.

INTC should be treated as an event-driven turnaround rather than a peer valuation substitute. Government alignment can reduce financing and political risk, but it does not validate foundry economics; a credible external leading-edge customer, yield disclosure, and improving foundry losses are the required proof points over 6-18 months. Without those milestones, capital intensity and dilution/financing risk can overwhelm any cyclical improvement in PC or server demand.

Consensus is broadly right on AVGO quality but may be too linear on AI revenue growth at a premium multiple. Near term, bespoke silicon announcements can sustain momentum; over 1-3 months, the relevant catalyst is whether AI backlog converts without weaker software renewals or networking inventory corrections. A guide-down in AI growth, a materially lower semiconductor gross-margin outlook, or adverse EU remedy would challenge the long thesis faster than an absolute demand decline.

Key Decisions for Investors

• Maintain an AVGO core long only on post-earnings weakness rather than chase AI-contract headlines; target a 6-12 month holding period. Size against a 10-15% drawdown risk from multiple compression if next-quarter AI growth decelerates or gross-margin guidance disappoints.
• Express the supply-chain bottleneck through long TSM versus short SOXX for 3-6 months: TSM captures diversified advanced-node demand while SOXX retains broader memory, analog and cyclical exposure. Exit if leading-edge utilization/capex commentary weakens or Taiwan geopolitical risk materially reprices.
• Avoid directional INTC exposure until an independently identified external foundry customer and economics/yield milestones are disclosed. For a catalyst trade, consider a small long INTC / short SMH position only after confirmation; invalidate on renewed negative free cash flow or a foundry-loss expansion at the next earnings report.
• Use AVGO downside protection around earnings via a 3-6 month put spread rather than reducing the entire position: the asymmetric risk is a premium-multiple reset from an AI conversion or margin miss, while upside from incremental customer awards is likely partly anticipated.